Aprogen Subsidiary Appteon Issues 10 Billion Won Convertible Bonds for R&D, High Dilution Risk and Weak Counterparty Pose Concerns
Aprogen's subsidiary Appteon decided to issue 10 billion won in 10th series unregistered private convertible bonds due July 24, 2031, with 0% coupon and 3% yield to maturity.
Conversion price is set at 1,000 won per share, leading to 10 million new shares upon conversion, equivalent to 33.71% of Appteon's outstanding shares, causing significant dilution at the subsidiary level.
Proceeds will be used for operating funds for new business and R&D. However, the counterparty Free Zhen Technology Investment Association has total assets of only 21 million won, indicating weak creditworthiness and high counterparty risk.
The company has no plan for treasury stock acquisition or cancellation. Existing outstanding convertible bonds total 99.4 billion won, adding to dilution pressure.
[AI Summary]This convertible bond issuance by subsidiary Appteon adds potential dilution to Aprogen's consolidated equity, with the offering size at 17% of market capitalization, raising concerns over shareholder value. Weak counterparty credit and uncertain use of funds heighten investment risks.
KOSPI Filing Information
Report on Major Events (Decision on Issuance of Convertible Bonds) (Major Management Matters of Subsidiary) (10th Series)